Best cancer prevention stocks
Chuck Saletta (Amgen): Recent news from Amgen led several stocks in the cancer-treatment sector higher. The news that moved the needle? Amgen had some positive data come out from human trials of a treatment that helped inhibit KRAS -- a protein whose mutations are often linked to aggressive cancers. Interest in immunotherapies continues to build up - earlier this week, Loncar Cancer Immunotherapy ETF CNCR , the first ETF dedicated only to stocks. 5 Immunotherapy Stocks to Watch for Treating